Menopause Stem Cell Treatment Explained

Gynecologists have observed that for some reason nearly 50% of patients with early menopause do not respond well to the usual hormone replacement therapy with estrogen and progesterone, for reasons unknown.
Nature must assure the continuity of life by a perfect control of procreation.

Function of all organs of procreation must be perfectly regulated. The regulation in the female body is not only a matter of taking estrogen and progesterone, it is run by an automonous nervous system directed by hypothalamus, a very important part of the central nervous system, and managed by the endocrine system, with the pituitary being the ‘master gland’ directing the rest of hormones producing glands.

Lack of some hormones can be substituted by hormonal therapy, however stem cells have been shown to rejuvenate the hypothalamus, and coordinate all glands of the endocrine system to function synergistically.

Premature menopause is apparently caused due to the stress and pressures of high level jobs, requiring long hours, intense competition, hectic lifestyle, inadequate nutrition up to starvation, and other factors. An increasing number of young women in their early thirties stop menstruating, and soon develop classical symptoms of menopause, and of the complications associated with menopause.

Hormone levels generally affected are:

• Estrogen
• Progesterone
• Pituitary follicle-stimulating hormone (FSH)
• Pituitary luteinizing hormone (LH)
• Pituitary prolactine
• Cortisol
• Thyroid hormones
• Pituitary thyroid-stimulating hormone (TSH)

Menopause Stem Cell Treatment

These levels will start to return normal after 4 weeks therapy and remain normal for around 4-6 months, at this stage patients will generally see a return to menopause levels of these hormones. However, they will not return to as low as prior to menopause stem cell treatment.

At this stage we advise patients to have a follow up therapy which will normalise the hormones levels, but at the follow up stage an increased duration of normalised levels will be seen 9-12 months. This structure will increase with each follow up. With each subsequent cell transplantation the duration of clinical effect lasts longer. This is also related to the number of cells elected in the menopause stem cell treatment program, the higher the number the greater the impact.